Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Tiziana Life Sciences Ltd (TLSA)

$0.95 -0.06 (-5.50%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	127.26M
Revenue (ttm)	0.00
Net Income (ttm)	-18.43M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	418,200
Avg Vol	249,394
Day's Range	N/A - N/A
Shares Out	127.26M
Stochastic %K	6%
Beta	0.46
Analysts	Sell
Price Target	$9.00

Company Profile

Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R mono...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 20 7495 2379

Website: www.tizianalifesciences.com

Address:

14/15 Conduit Street, London, United Kingdom

Doubleup2022 Jul. 22 at 8:06 PM

$TLSA Losing 360 is gonna send this pig to 230. Yayaya

0 · Reply

WHATABOUTSTOCKS Jul. 22 at 6:34 PM

$TLSA gap $0,45 !!

0 · Reply

Fedrano175 Jul. 22 at 11:54 AM

$TLSA Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

0 · Reply

WHATABOUTSTOCKS Jul. 21 at 8:16 PM

$TLSA TITziana life sciences reverse split

1 · Reply

Housatonic1864 Jul. 21 at 8:15 PM

$TLSA new low🏴‍☠️

0 · Reply

Fedrano175 Jul. 21 at 4:50 PM

$TLSA buy others 🙌 We have to hold out until the end of October!

0 · Reply

Iceman89 Jul. 21 at 3:40 PM

$TLSA Sad!

2 · Reply

JuggernautRaider Jul. 21 at 1:50 PM

$HELP 🧐 what is this? Why don’t i own this potential MDD warrior like I do $TNXP $TLSA or $CGTX @Willy_Nilly they just completed their phase 3 ahead of schedule… 🧠

2 · Reply

JuggernautRaider Jul. 21 at 10:31 AM

$TLSA buying more 💷

0 · Reply

rp6577 Jul. 20 at 6:23 PM

$TLSA added $XBI

0 · Reply

Tiziana Life Sciences chairman Gabriele Cerrone purchases 42,357 shares at 99c

Jul 22, 2026, 7:00 AM EDT - 21 hours ago

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

2026-06-25T11:20:37.000Z - 27 days ago

Tiziana Life Sciences doses last patient in intranasal foralumab trial

Jun 25, 2026, 7:00 AM EDT - 27 days ago

Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial

2026-06-15T11:42:42.000Z - 5 weeks ago

Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares

May 28, 2026, 7:00 AM EDT - 7 weeks ago

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York

2026-05-21T15:05:09.000Z - 2 months ago

Tiziana fully enrolls Phase 2 placebo-controlled MS trial

May 21, 2026, 11:00 AM EDT - 2 months ago

Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial

2026-05-19T12:13:28.000Z - 2 months ago

Tiziana Life Sciences announces updated intranasal foralumab data

May 19, 2026, 7:00 AM EDT - 2 months ago

Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

2026-05-14T13:46:05.000Z - 2 months ago

Tiziana Phase 2 trial for foralumab shows reduced brain inflammation

May 14, 2026, 7:00 AM EDT - 2 months ago

Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab

2026-04-16T12:01:24.000Z - 3 months ago

Tiziana Life announces publication of preclinical data in bioRxiv preprint

Apr 16, 2026, 7:00 AM EDT - 3 months ago

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function

Apr 14, 2026, 7:00 AM EDT - 3 months ago

Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress

Apr 1, 2026, 7:00 AM EDT - 4 months ago

Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging

2026-02-25T12:25:15.000Z - 5 months ago

Tiziana Life Sciences announces new data on nasal foralumab

Feb 25, 2026, 7:00 AM EST - 5 months ago

Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA

2026-01-20T16:20:10.000Z - 6 months ago

Tiziana Life Sciences announces publication of intranasal foralumab results

Jan 20, 2026, 11:15 AM EST - 6 months ago

Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab

Jan 16, 2026, 2:45 PM EST - 6 months ago

Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares

2026-01-16T12:05:16.000Z - 6 months ago

Tiziana Life Sciences prices 6.4M shares at $1.25 in registered direct offering

Jan 16, 2026, 7:00 AM EST - 6 months ago

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million

Jan 9, 2026, 7:00 AM EST - 6 months ago

Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco

2025-12-29T13:15:44.000Z - 7 months ago

Tiziana Life Sciences files annual safety report for intranasal foralumab

Dec 29, 2025, 8:00 AM EST - 7 months ago

Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA

2025-12-19T16:05:39.000Z - 7 months ago

Tiziana Life Sciences Chairman raises stake to 36% with acquisition of shares

Dec 19, 2025, 11:00 AM EST - 7 months ago

Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman

Dec 17, 2025, 10:00 AM EST - 7 months ago

Tiziana Life Sciences to Ring the Closing Bell at Nasdaq

2025-12-17T13:50:17.000Z - 7 months ago

Tiziana Life Sciences doses first patient in Phase 2 Alzheimer’s trial

Dec 17, 2025, 8:45 AM EST - 7 months ago

Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer's Clinical Trial

2025-12-15T20:15:08.000Z - 7 months ago

Tiziana Life Sciences CEO Ivor Elrifi purchases 163,400 shares

Dec 15, 2025, 3:07 PM EST - 7 months ago

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

2025-12-15T12:35:32.000Z - 7 months ago

Tiziana Life Sciences announces withdrawal of proposed public offering

Dec 15, 2025, 7:30 AM EST - 7 months ago

Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering

2025-12-12T19:15:11.000Z - 7 months ago

Tiziana Life Sciences to dose first patient in Phase 2 Alzheimer’s trial

Dec 12, 2025, 2:10 PM EST - 7 months ago

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial

2025-12-02T12:05:39.000Z - 8 months ago

Tiziana Life Sciences plans to spinout IL-6 asset into separate listed company

Dec 2, 2025, 7:00 AM EST - 8 months ago

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company

2025-11-25T13:40:48.000Z - 8 months ago

Tiziana Life announces Phase 2 foralumab study accepted into Healey ALS program

Nov 25, 2025, 8:30 AM EST - 8 months ago

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

Nov 13, 2025, 8:30 AM EST - 8 months ago

Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference

2025-10-29T11:22:32.000Z - 9 months ago

Tiziana Life Sciences to present at BIO-Europe in Vienna

Oct 29, 2025, 7:00 AM EDT - 9 months ago

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy

Sep 30, 2025, 8:30 AM EDT - 10 months ago

Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia

Sep 24, 2025, 8:30 AM EDT - 10 months ago

Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress

Sep 15, 2025, 8:00 AM EDT - 11 months ago

Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury

Sep 5, 2025, 8:30 AM EDT - 11 months ago

Tiziana Life Sciences Announces Purchase of Shares by Chairman

Aug 14, 2025, 8:30 AM EDT - 1 year ago

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy

Aug 11, 2025, 9:00 AM EDT - 1 year ago

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

Jul 21, 2025, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient

Jun 13, 2025, 10:30 AM EDT - 1 year ago

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

Jun 13, 2025, 8:30 AM EDT - 1 year ago

Tiziana Life Sciences to Present at the Bio International Convention

May 23, 2025, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease

May 15, 2025, 8:00 AM EDT - 1 year ago

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal Foralumab in Study Treating Moderate Alzheimer's Disease

May 9, 2025, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab

May 6, 2025, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis

Apr 23, 2025, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial

Mar 25, 2025, 8:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial

Mar 17, 2025, 8:00 AM EDT - 1 year ago

Tiziana Life Sciences to Present at the 37th Annual Roth Conference

Mar 14, 2025, 8:30 AM EDT - 1 year ago

Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule

Mar 4, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial

Feb 27, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury

Feb 25, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter

Feb 21, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC

Feb 18, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program

Feb 11, 2025, 9:15 AM EST - 1 year ago

Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer's Disease

Jan 23, 2025, 3:00 PM EST - 1 year ago

Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3

Doubleup2022 Jul. 22 at 8:06 PM

$TLSA Losing 360 is gonna send this pig to 230. Yayaya

0 · Reply

WHATABOUTSTOCKS Jul. 22 at 6:34 PM

$TLSA gap $0,45 !!

0 · Reply

Fedrano175 Jul. 22 at 11:54 AM

$TLSA Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

0 · Reply

WHATABOUTSTOCKS Jul. 21 at 8:16 PM

$TLSA TITziana life sciences reverse split

1 · Reply

Housatonic1864 Jul. 21 at 8:15 PM

$TLSA new low🏴‍☠️

0 · Reply

Fedrano175 Jul. 21 at 4:50 PM

$TLSA buy others 🙌 We have to hold out until the end of October!

0 · Reply

Iceman89 Jul. 21 at 3:40 PM

$TLSA Sad!

2 · Reply

JuggernautRaider Jul. 21 at 1:50 PM

$HELP 🧐 what is this? Why don’t i own this potential MDD warrior like I do $TNXP $TLSA or $CGTX @Willy_Nilly they just completed their phase 3 ahead of schedule… 🧠

2 · Reply

JuggernautRaider Jul. 21 at 10:31 AM

$TLSA buying more 💷

0 · Reply

rp6577 Jul. 20 at 6:23 PM

$TLSA added $XBI

0 · Reply

LDCap Jul. 18 at 12:50 PM

$TLSA started a small position with 40k shares. Will add more till readout. Everything looks good on DD.

0 · Reply

Ic0gcds000 Jul. 18 at 4:12 AM

$TLSA every where is red Just the markets

0 · Reply

Housatonic1864 Jul. 17 at 10:04 PM

$TLSA almost at the year low🫡 Party time 🥳 😂🫡💥

0 · Reply

rp6577 Jul. 16 at 11:32 AM

$TLSA I wonder if the price action had something to do with the warrants expiring

1 · Reply

WHATABOUTSTOCKS Jul. 15 at 7:53 PM

$TLSA TITziana life sciences

0 · Reply

Housatonic1864 Jul. 15 at 5:43 PM

$TLSA Shareholders need a big fat juicy PR💥

1 · Reply

rp6577 Jul. 15 at 5:38 PM

$TLSA getting plenty of opportunity to build a position ahead of the phase 2a data in September/October! $XBI

0 · Reply

WHATABOUTSTOCKS Jul. 15 at 5:07 PM

$TLSA lets gooooooooo !!!!!

0 · Reply

Iceman89 Jul. 15 at 3:59 PM

$TLSA Bought more shares. Wooo!!!

0 · Reply

Housatonic1864 Jul. 14 at 10:14 PM

$TLSA have a feeling that by mid October, this will be soaring with the big dogs💥

0 · Reply

rp6577 Jul. 14 at 8:04 PM

$TLSA odd price action at the end of the day. There was 80k shares sitting on the ask at the close. Not sure if it’s shorts playing games or the company using the ATM. Although I wouldn’t have though the company would have been so abrupt

2 · Reply

Chellybaby Jul. 14 at 6:16 PM

$TLSA been in this for 4 years plus. However wish I had the balls to trade it, thing runs up like clockwork every couple of months. Almost set your watch to it

1 · Reply

1.0.0